Half-fluence Photodynamic Therapy for Central Serous Chorioretinopathy in a Patient Receiving Corticosteroids for Behçet's Uveitis

Özdemir, Hüseyin Baran; Zhoroeva, Nazgül; Çakar Özdal, Pinar; Özdek, Sengül

Özdemir, Hüseyin Baran; Zhoroeva, Nazgül; Çakar Özdal, Pinar; Özdek, Sengül.

Affiliation

Özdemir HB; Gazi University Faculty of Medicine, Department of Ophthalmology, Ankara, Turkey
Zhoroeva N; Gazi University Faculty of Medicine, Department of Ophthalmology, Ankara, Turkey
Çakar Özdal P; University of Health Sciences Turkey, Ulucanlar Eye Training and Research Hospital, Clinic of Ophthalmology, Ankara, Turkey
Özdek S; Gazi University Faculty of Medicine, Department of Ophthalmology, Ankara, Turkey

Turk J Ophthalmol ; 52(2): 142-146, 2022 04 28.

Article in En | MEDLINE | ID: mdl-35481736

Subject(s)

Behcet Syndrome; Central Serous Chorioretinopathy; Photochemotherapy; Uveitis; Adrenal Cortex Hormones/therapeutic use; Adult; Behcet Syndrome/complications; Behcet Syndrome/diagnosis; Behcet Syndrome/drug therapy; Central Serous Chorioretinopathy/chemically induced; Central Serous Chorioretinopathy/diagnosis; Central Serous Chorioretinopathy/drug therapy; Fluorescein Angiography; Humans; Male; Photochemotherapy/adverse effects; Photosensitizing Agents/adverse effects; Tomography, Optical Coherence; Uveitis/drug therapy; Verteporfin/therapeutic use

Key words

Behçet's disease; central serous chorioretinopathy; photodynamic therapy; steroid; uveitis

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Photochemotherapy / Uveitis / Behcet Syndrome / Central Serous Chorioretinopathy Type of study: Diagnostic_studies Language: En Journal: Turk J Ophthalmol Year: 2022 Type: Article Affiliation country: Turkey

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google